A base editing resource for functional annotation of DNA repair variants in breast-derived cell models

Wardah Masud1,2, Ludovica Russo3, Vincent Chapdelaine-Trépanier1,2

  • 1Department of Human Genetics, McGill University, Montreal, QC, Canada.

Abstract

Insights

This study uses CRISPR base editing screens to functionally test DNA damage response (DDR) gene variants in triple-negative breast cancer cells. The results help interpret variants of uncertain significance for precision oncology.

Area of Science:

  • Genomics
  • Cancer Biology
  • Molecular Biology

Background:

  • The DNA damage response (DDR) is crucial for maintaining genome integrity.
  • Disruptions in DDR genes are implicated in cancer development and treatment resistance.
  • Thousands of DDR gene variants in tumors lack clear functional interpretation, hindering clinical application.

Purpose of the Study:

  • To functionally characterize DNA damage response (DDR) gene variants in triple-negative breast cancer (TNBC).
  • To extend previous CRISPR-based screening efforts to a new cell line model (MDA-MB-231).
  • To create a dataset for stratifying variants of uncertain significance and advancing precision oncology.

Main Methods:

  • Performed a large-scale CRISPR-dependent base editing screen in MDA-MB-231 cells.
  • Assessed the impact of approximately 11,000 single-guide RNAs (sgRNAs) on cellular fitness.
  • Targeted the coding sequences of 27 DDR genes, focusing on homologous recombination (HR) and inter-strand crosslink repair (ICLR) pathways.

Main Results:

  • Generated a dataset of functional consequences for thousands of DDR variants in TNBC.
  • Integrated mutation-associated effects with clinical annotations for variant stratification.
  • Identified shared and context-specific genetic dependencies across different breast cancer cell lines.

Conclusions:

  • The study provides a standardized, cross-comparable resource for interpreting DDR variants.
  • This resource is expected to facilitate the development of precision oncology strategies.
  • Advances the functional understanding of DDR variants in cancer, aiding clinical decision-making.

Related Concept Videos